Reuters Health News Summary
Read more about Reuters Health News Summary on Devdiscourse
DevdiscourseOct 31, 2026
Read full articleLatest News
Reuters Health News Summary
Read more about Reuters Health News Summary on Devdiscourse
DevdiscourseOct 31, 2026
Read full articleReuters Health News Summary
Read more about Reuters Health News Summary on Devdiscourse
DevdiscourseOct 31, 2026
Read full article
Global Markets | European shares stumble at end of best month since June on AI worries
European stock markets slid as a global selloff in technology rattled investors, with the pan-European STOXX 600 index closing in negative territory. Concerns over soaring AI infrastructure costs loomed large. However, to add a silver lining, euro zone growth exceeded forecasts amid climbing inflation and borrowing costs, while firms such as Universal Music Group and Sanofi flaunted impressive earnings in these challenging times.
The Economic TimesOct 31, 2026
Read full articleReuters Health News Summary
Read more about Reuters Health News Summary on Devdiscourse
DevdiscourseOct 30, 2026
Read full article
UPDATE 1-Bayer wins Roundup weedkiller cancer trial while awaiting settlement ruling
Read more about UPDATE 1-Bayer wins Roundup weedkiller cancer trial while awaiting settlement ruling on Devdiscourse
DevdiscourseOct 30, 2026
Read full article
Heavyweight tech stocks plummet as AI cash burn spooks investors
European technology shares posted their worst day since July
The Irish TimesOct 30, 2026
Read full article
European shares stumble at end of best month since June on AI worries
Read more about European shares stumble at end of best month since June on AI worries on Devdiscourse
DevdiscourseOct 30, 2026
Read full article
US jury backs Bayer in weedkiller cancer case
A US jury has sided with the multinational company Bayer over three women’s claims its Roundup weedkiller caused their cancer, the latest blow to plaintiffs in thousands of similar cases.
Bangkok PostOct 30, 2026
Read full article
Bayer wins Roundup cancer trial amid settlement ruling
Bayer wins Roundup cancer trial as it awaits ruling on a US$7.25 billion settlement for thousands of other claims. Read more at straitstimes.com.
The Straits TimesOct 30, 2026
Read full article